Related Drugs
Cefmenoxime Hydrochloride for Injection
Indication: This product is suitable for the following infections caused by ceftriaxone-sensitive Streptococci (except enterococci), Streptococcus pneumoniae, Peptococcus, Peptostreptococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Haemophilus influenzae, Bacteroides, etc.: 1. Pneumonia, bronchitis, bronchiectasis infection, secondary infection of chronic respiratory diseases; lung abscess, empyema; 2. Pyelonephritis, cystitis; Bartholinitis, endometritis, adnexitis, pelvic inflammatory disease, parametrial tissue inflammation; 3. Cholangitis, cholecystitis, liver abscess, peritonitis; 4. Secondary infection of burns and surgical trauma; 5. Sepsis; 6. Meningitis.
Manufacturer:
Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.
Cefmenoxime Hydrochloride for Injection
Indication: This product is suitable for the following infections caused by ceftriaxone-sensitive Streptococci (except enterococci), Streptococcus pneumoniae, Peptococcus, Peptostreptococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Haemophilus influenzae, Bacteroides, etc.: 1. Pneumonia, bronchitis, bronchiectasis infection, secondary infection of chronic respiratory diseases; lung abscess, empyema; 2. Pyelonephritis, cystitis; Bartholinitis, endometritis, adnexitis, pelvic inflammatory disease, parametrial tissue inflammation; 3. Cholangitis, cholecystitis, liver abscess, peritonitis; 4. Secondary infection of burns and surgical trauma; 5. Sepsis; 6. Meningitis.
Manufacturer:
Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.
Cefmenoxime Hydrochloride for Injection
Indication: This product is suitable for the following infections caused by ceftriaxone-sensitive Streptococci (except enterococci), Streptococcus pneumoniae, Peptococcus, Peptostreptococcus, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Haemophilus influenzae, Bacteroides, etc.: 1. Pneumonia, bronchitis, bronchiectasis infection, secondary infection of chronic respiratory diseases; lung abscess, empyema; 2. Pyelonephritis, cystitis; Bartholinitis, endometritis, adnexitis, pelvic inflammatory disease, parametrial tissue inflammation; 3. Cholangitis, cholecystitis, liver abscess, peritonitis; 4. Secondary infection of burns and surgical trauma; 5. Sepsis; 6. Meningitis.
Clindamycin Hydrochloride and Sodium Chloride Injection
Indication: 1. For the treatment of the following infectious diseases caused by Gram-positive bacteria: (1) tonsillitis, suppurative otitis media, sinusitis, etc.; (2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc.; (3) skin and soft tissue infections: furuncle, carbuncle, abscess, fossa inflammation, trauma and postoperative infection, etc.; (4) urinary tract infections: acute urethritis, acute pyelonephritis, prostatitis, etc.; (5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc.; 2. For the treatment of various infectious diseases caused by anaerobic bacteria: (1) empyema, lung abscess, anaerobic lung disease; (2) skin and soft tissue infections, sepsis; (3) intra-abdominal infections: peritonitis, intra-abdominal abscess; (4) female pelvic and genital infections: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa inflammation and post-gynecological surgery infection, etc.
Clindamycin Hydrochloride and Sodium Chloride Injection
Indication: 1. For the treatment of the following infectious diseases caused by Gram-positive bacteria: (1) tonsillitis, suppurative otitis media, sinusitis, etc.; (2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc.; (3) skin and soft tissue infections: furuncle, carbuncle, abscess, fossa inflammation, trauma and postoperative infection, etc.; (4) urinary tract infections: acute urethritis, acute pyelonephritis, prostatitis, etc.; (5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc.; 2. For the treatment of various infectious diseases caused by anaerobic bacteria: (1) empyema, lung abscess, anaerobic lung disease; (2) skin and soft tissue infections, sepsis; (3) intra-abdominal infections: peritonitis, intra-abdominal abscess; (4) female pelvic and genital infections: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa inflammation and post-gynecological surgery infection, etc.
Clindamycin Hydrochloride and Sodium Chloride Injection
Indication: 1. The product is suitable for the following infectious diseases caused by Gram-positive bacteria: 1) tonsillitis, suppurative otitis media, sinusitis, etc. 2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc. 3) skin and soft tissue infection; furuncle, carbuncle, abscess, fossa tissue inflammation, trauma and postoperative infection, etc. 4) urinary system infection: acute urethritis, acute pyelonephritis, prostatitis, etc. 5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc. 2. The product is suitable for various infectious diseases caused by anaerobic bacteria: 1) empyema, lung abscess, anaerobic lung disease. 2) skin and soft tissue infection, sepsis. 3) intra-abdominal infection: peritonitis, intra-abdominal abscess. 4) female pelvic and genital infection: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa tissue inflammation and post-gynecological surgery infection, etc.
Manufacturer:
Guangdong Litai Pharmaceutical Holdings Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:
North China Pharmaceutical Company.Ltd
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:
Xiangbei Welman Pharmaceutical Co., Ltd.
Piperacillin Sodium and Tazobactam Sodium for Injection
Indication: This product is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin-tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides (Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron or Bacteroides vulgaris). 2. Uncomplicated and complicated skin and soft tissue infections caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus, including cellulitis, skin abscesses, ischemic or diabetic foot infections. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (hospital pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treat systemic and/or local bacterial infections caused by sensitive bacteria.
Manufacturer:
Xiangbei Welman Pharmaceutical Co., Ltd.